Table 2 Patient Characteristics at Transfer to Adult Center
From: Kidney transplant survival in pediatric and young adults
Transfer (n = 18) | |
|---|---|
Age at transfer | 18.6 ± 1.0 (range 16.6-20.9 years) |
Gender (male) | 9 |
ESRD | |
Congenital | 6 |
Glomerulonephritis | 7 |
Interstitial | 3 |
Other | 2 |
Duration of Function | 5.1 ± 3.5 (range 0.9-11 years) |
Deceased Donor | 11 |
1st Graft | 13 |
HLA MM | 3.5 ± 1.2 |
Number of patients with rejection pre transfer | 7 |
Donor Age (years) | 39 ± 12 |
Systolic BP | 127 ± 11 mm Hg |
Albumin | 40 ± 3 g/L |
Hemoglobin | 112 ± 19 g/L |
Phosphorous | 1.27 ± 0.47 mmol/L |
Serum Creatinine | |
Year 1 Post Transplant | 208 ± 132 μmol/L |
At Transfer | 182 ± 81 μmol/L |
12 months Post Transfer | 226 ± 170 μmol/L |
Mean Laboratory tests | |
12 months pre | 28 ± 27 |
12 months post | 15 ± 9 |
Number of patients with rejection post transfer | 5 |
Mean Follow up | 4.92 years |
Immunosuppression | |
Tacrolimus | 10 |
Cyclosporine | 7 |
Azathioprine | 11 |
MMF | 3 |
Sirolimus | 1 |
Prednisone | 18 |